journal article·2024-05-15Open access

Preparation and In Vitro Characterization of Lactococcus lactis-Loaded Alginate Particles as a Promising Delivery Tool for Periodontal Probiotic Therapy

Bettina Wuttke, Katharina Ekat, Oleksandra Chabanovska, Mario Jackszis, Armin Springer, Praveen Vasudevan, Bernd Kreikemeyer, Hermann Lang

Abstract

Probiotic microorganisms are used in a variety of food supplements and medical formulations to promote human health. In periodontal therapy, probiotics are mainly used in the form of gels, tablets or rinses that often tend to leak from the periodontal pocket, resulting in a strongly reduced therapeutic effect. In this pilot in vitro study, we present biodegradable alginate-based particles as an alternative, highly efficient system for a periodontal delivery of probiotic bacteria to the inflammation site. For this purpose, Lactococcus (L.) lactis was encapsulated using a standardized pump-controlled extrusion-dripping method. Time-dependent bacterial release in artificial saliva was investigated over 9 days. The effect of freeze drying was explored to ensure long-term storage of L. lactis-loaded particles. Additionally, the particles were bound to dentin surface using approved bioadhesives and subjected to shear stress in a hydrodynamic flow chamber that mimics the oral cavity in vitro. Thus, round particles within the range of 0.80–1.75 mm in radius could be produced, whereby the diameter of the dripping tip had the most significant impact on the size. Although both small and large particles demonstrated a similar release trend of L. lactis, the release rate was significantly higher in the former. Following lyophilization, particles could restore their original shape within 4 h in artificial saliva; thereby, the bacterial viability was not affected. The attachment strength to dentin intensified by an adhesive could resist forces between 10 and 25 N/m2. Full degradation of the particles was observed after 20 days in artificial saliva. Therefore, alginate particles display a valuable probiotic carrier for periodontal applications that have several crucial advantages over existing preparations: a highly stable form, prolonged continuous release of therapeutic bacteria, precise manufacturing according to required dimensions at the application site, strong attachment to the tooth with low risk of dislocation, high biocompatibility and biodegradability.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Probiotics and Fermented Foods · Oral microbiology and periodontitis research · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Operative Dentistry and Periodontology, University Medical Center Rostock, 18057 Rostock, Germany

Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Rostock, 18057 Rostock, Germany

Biomechanics and Implant Technology Research Laboratory, Department of Orthopedics, University Medical Center Rostock, 18057 Rostock, Germany

Medical Biology and Electron Microscopy Centre, University Medical Center Rostock, 18057 Rostock, Germany

References (100+)

Show source-provided references
1. Immunomicrobial Pathogenesis of Periodontitis: Keystones, Pathobionts, and Host Response10.1016/j.it.2013.09.001 ↗
2. Global Burden of Severe Periodontitis in 1990–2010: A Systematic Review and Meta-Regression10.1177/0022034514552491 ↗
3. Periodontitis: A Polymicrobial Disruption of Host Homeostasis10.1038/nrmicro2337 ↗
4. Periodontal Diseases10.1038/nrdp.2017.38 ↗
5. How Has Research into Cytokine Interactions and Their Role in Driving Immune Responses Impacted Our Understanding of Periodontitis?10.1111/j.1600-051X.2010.01671.x ↗
6. How, K.Y., Song, K.P., and Chan, K.G. (2016). Porphyromonas Gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front. Microbiol., 7.10.3389/fmicb.2016.00053 ↗
7. Anti-Tumor Necrosis Factor Ameliorates Joint Disease in Murine Collagen-Induced Arthritis
8. Jordan, A.R., and Micheelis, W. (2016). Fünfte Deutsche Mundgesundheitsstudie (DMS V), Deutscher Zahnärzte Verlag DÄV.
9. Experimental Gingivitis in Man10.1902/jop.1965.36.3.177 ↗
10. Non-Surgical Periodontal Therapy with Systemic Antibiotics in Patients with Untreated Chronic Periodontitis: A Systematic Review and Meta-Analysis10.1111/jre.12221 ↗
11. Antibiotic Resistance in Human Chronic Periodontitis Microbiota10.1902/jop.2013.130142 ↗
12. Sanderink, R., Renggli, H.H., and Saxer, U.P. (2022). Orale Präventivmedizin, Georg Thieme Verlag KG.10.1055/b-006-149528 ↗
13. Nutritional Stimulation of Commensal Oral Bacteria Suppresses Pathogens: The Prebiotic Concept10.1111/jcpe.12700 ↗
14. Probiotika Im Rahmen Der Antiinfektiösen Therapie Der Parodontitis10.1007/s11838-018-0065-3 ↗
15. Clinical Efficacy of Probiotics as an Adjunctive Therapy to Non-Surgical Periodontal Treatment of Chronic Periodontitis: A Systematic Review and Meta-Analysis10.1111/jcpe.12545 ↗
16. Do Probiotics Offer Opportunities to Manipulate the Periodontal Oral Microbiota?10.1111/j.1600-051X.2010.01665.x ↗
17. Clinical and Microbiological Effects of Lactobacillus Reuteri Probiotics in the Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Study10.1111/jcpe.12155 ↗
18. Antimicrobial Activity of Streptococcus Salivarius K12 on Bacteria Involved in Oral Malodour10.1016/j.archoralbio.2012.02.011 ↗
19. Inhibitory Activity in Vitro of Probiotic Lactobacilli against Oral Candida under Different Fermentation Conditions10.3920/BM2014.0054 ↗
20. Nishihara, T., Suzuki, N., Yoneda, M., and Hirofuji, T. (2014). Effects of Lactobacillus Salivarius-Containing Tablets on Caries Risk Factors: A Randomized Open-Label Clinical Trial. BMC Oral Health, 14.10.1186/1472-6831-14-110 ↗
21. Probiotics and Oral Healthcare10.1111/j.1600-0757.2008.00254.x ↗
22. Consumption of Lactobacillus Reuteri-Containing Lozenges Improves Periodontal Health in Navy Sailors at Sea: A Randomized Controlled Trial10.1002/JPER.19-0393 ↗
23. The Effect of a Streptococci Containing Probiotic in Periodontal Therapy: A Randomized Controlled Trial10.1111/jcpe.12464 ↗
24. Probiotics and Periodontal Disease10.1111/j.1600-0757.2009.00305.x ↗
25. Wilson, M. (2010). Microbial Inhabitants of Humans, Cambridge University Press.
26. Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus Reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Chronic Periodontitis10.1902/jop.2015.140612 ↗
27. Jones, S.E., and Versalovic, J. (2009). Probiotic Lactobacillus Reuteri Biofilms Produce Antimicrobial and Anti-Inflammatory Factors. BMC Microbiol., 9.10.1186/1471-2180-9-35 ↗
28. Aciduric Strains of Lactobacillus Reuteri and Lactobacillus Rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties10.1007/s12602-017-9307-5 ↗
29. Clinical and Microbiological Effects of Probiotic Lozenges in the Treatment of Chronic Periodontitis: A 1-Year Follow-up Study10.1111/jcpe.12387 ↗
30. Decreased Gum Bleeding and Reduced Gingivitis by the Probiotic Lactobacillus Reuteri
31. Clinical Effects of Lactobacillus Rhamnosus in Non-Surgical Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Trial With 1-Year Follow-Up10.1902/jop.2016.150665 ↗
32. Probiotics for Gastrointestinal Conditions: A Summary of the Evidence
33. The Lactic Acid Bacteria, the Food Chain, and Their Regulation10.1016/j.tifs.2004.03.003 ↗
34. Flavour Formation by Lactic Acid Bacteria and Biochemical Flavour Profiling of Cheese Products10.1016/j.fmrre.2005.04.002 ↗
35. Inhibitory Effect of Lactococcus Lactis on the Bioactivity of Periodontopathogens10.2323/jgam.2017.06.003 ↗
36. Development of Postbiotics by Whey Bioconversion with Enterococcus Faecalis M157 KACC81148BP and Lactococcus Lactis CAU2013 KACC81152BP for Treating Periodontal Disease and Improving Gut Health10.3168/jds.2021-20616 ↗
37. Gao, L., Kuraji, R., Zhang, M.J., Martinez, A., Radaic, A., Kamarajan, P., Le, C., Zhan, L., Ye, C., and Rangé, H. (2022). Nisin Probiotic Prevents Inflammatory Bone Loss While Promoting Reparative Proliferation and a Healthy Microbiome. NPJ Biofilms Microbiomes, 8.10.1038/s41522-022-00307-x ↗
38. Radaic, A., Brody, H., Contreras, F., Hajfathalian, M., Lucido, L., Kamarajan, P., and Kapila, Y.L. (2022). Nisin and Nisin Probiotic Disrupt Oral Pathogenic Biofilms and Restore Their Microbiome Composition towards Healthy Control Levels in a Peri-Implantitis Setting. Microorganisms, 10.10.3390/microorganisms10071336 ↗
39. Radaic, A., Ye, C., Parks, B., Gao, L., Kuraji, R., Malone, E., Kamarajan, P., Zhan, L., and Kapila, Y.L. (2020). Modulation of Pathogenic Oral Biofilms towards Health with Nisin Probiotic. J. Oral Microbiol., 12.10.1080/20002297.2020.1809302 ↗
40. Alginates as Biomaterials in Tissue Engineering
41. Alginate-Poloxamer Microparticles for Controlled Drug Delivery to Mucosal Tissue10.1016/j.ejpb.2008.12.004 ↗
42. Improvement of Stability of Oil-in-Water Emulsions Containing Caseinate-Coated Droplets by Addition of Sodium Alginate10.1111/j.1750-3841.2007.00534.x ↗
43. Immobilization of Cells for Application in the Food Industry10.3109/07388559409086963 ↗
44. Alginate Impressions: A Practical Perspective10.4103/0972-0707.43416 ↗
45. Johnston, D., Choonara, Y.E., Kumar, P., Du Toit, L.C., Van Vuuren, S., and Pillay, V. (2013). Prolonged Delivery of Ciprofloxacin and Diclofenac Sodium from a Polymeric Fibre Device for the Treatment of Peridontal Disease. Biomed Res. Int., 2013.10.1155/2013/460936 ↗
46. Wang, X., Gao, S., Yun, S., Zhang, M., Peng, L., Li, Y., and Zhou, Y. (2022). Microencapsulating Alginate-Based Polymers for Probiotics Delivery Systems and Their Application. Pharmaceuticals, 15.10.3390/ph15050644 ↗
47. Genome Sequences of Lactococcus Lactis MG1363 (Revised) and NZ9000 and Comparative Physiological Studies10.1128/JB.00533-10 ↗
48. Prediction Models for Shape and Size of Ca-Alginate Macrobeads Produced Through Extrusion-Dripping Method10.1016/j.jcis.2009.05.027 ↗
49. Alginate Gel Particles–A Review of Production Techniques and Physical Properties10.1080/10408398.2014.965773 ↗
50. Size and Shape of Calcium Alginate Beads Produced by Extrusion Dripping10.1002/ceat.201300230 ↗
51. Alginate as Immobilization Matrix for Cells
52. Shape-Controlled Production of Biodegradable Calcium Alginate Gel Microparticles Using a Novel Microfluidic Device10.1021/la061729+ ↗
53. Ullah, S., Nawaz, A., Farid, A., Latif, M.S., Fareed, M., Ghazanfar, S., Galanakis, C.M., Alamri, A.S., Alhomrani, M., and Asdaq, S.M.B. (2022). Folate-Modified Chitosan 5-Flourouraci Nanoparticles-Embedded Calcium Alginate Beads for Colon Targeted Delivery. Pharmaceutics, 14.10.3390/pharmaceutics14071366 ↗
54. Response of Single Species Biofilms and Microcosm Dental Plaques to Pulsing with Chlorhexidine10.1093/jac/42.4.453 ↗
55. Development of Mucoadhesive Microbeads Using Thiolated Sodium Alginate for Intrapocket Delivery of Resveratrol10.1016/j.ijpharm.2015.04.010 ↗
56. Biophysical and Biological Characterization of Intraoral Multilayer Membranes as Potential Carriers: A New Drug Delivery System for Dentistry10.1016/j.msec.2016.10.032 ↗
57. Injectable Metronidazole-Eluting Gelatin-Alginate Hydrogels for Local Treatment of Periodontitis10.1177/08853282221079458 ↗
58. Alginate Hydrogels as Biomaterials10.1002/mabi.200600069 ↗
59. The Manufacturing Techniques of Drug-Loaded Polymeric Nanoparticles from Preformed Polymers10.3109/02652048.2011.569763 ↗
60. Sundararaghavan, H., and Burdick, J. (2017). Comprehensive Biomaterials II, Elsevier.
61. Sustained Local Delivery of Chlorhexidine in the Treatment of Periodontitis: A Multi-Center Study10.1902/jop.1997.68.1.32 ↗
62. Brunton, L.L., Hilal-Dandan, R., and Knollmann, B.C. (1996). The Pharmacological Basis of Therapeutics, 13e, McGraw-Hill Education.
63. Pharmacokinetic Principles Controlling Efficacy of Oral Therapy
64. Gingival Crevice Fluid Flow
65. Theory of Electrostatic Dispersion of Polymer Solutions in the Production of Microgel Beads Containing Biocatalyst10.1016/S0001-8686(97)00037-7 ↗
66. Food Protein-Based Materials as Nutraceutical Delivery Systems10.1016/j.tifs.2005.12.011 ↗
67. Investigation of Swelling/Degradation Behaviour of Alginate Beads Crosslinked with Ca2+ and Ba2+ Ions10.1016/j.reactfunctpolym.2004.01.002 ↗
68. Monitoring of Swelling and Degrading Behavior of Alginate Beads Using Optical Tweezers
69. Controlling Rigidity and Degradation of Alginate Hydrogels via Molecular Weight Distribution10.1021/bm049879r ↗
70. Alginate as Immobilization Material: I. Correlation between Chemical and Physical Properties of Alginate Gel Beads10.1002/bit.260330111 ↗
71. Hydrogels: From Controlled Release to pH-Responsive Drug Delivery10.1016/S1359-6446(02)02255-9 ↗
72. Messungen Der Kräfte Bei Kauvorgängen
73. Bite Force and Its Correlations in Different Denture Types10.3109/00016358509064142 ↗
74. Crueger, W., Esser, K., Präve, P., Schlingmann, M., Thauer, R., and Wagner, F. (1986). Jahrbuch Biotechnologie 1986, Hanser.
75. Encapsulation of Lactococcus Lactis in Alginate Microcapsules and Evaluation of the Survival in Simulated Gastrointestinal Conditions and during Milk Fermentation
76. Lactococcus Lactis Release from Calcium Alginate Beads10.1128/aem.58.5.1429-1434.1992 ↗
77. Spectrophotometric Quantification of Lactic Bacteria in Alginate and Control of Cell Release with Chitosan Coating10.1046/j.1365-2672.1998.00348.x ↗
78. FAO/WHO (2022). FAO/WHO Joint Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, FAO/WHO.
79. Evaluation of Encapsulation Techniques of Probiotics for Yoghurt10.1016/S0958-6946(02)00155-3 ↗
80. Yeung, T., Üçok, E., Tiani, K., McClements, D., and Sela, D. (2016). Microencapsulation in Alginate and Chitosan Microgels to Enhance Viability of Bifidobacterium Longum for Oral Delivery. Front. Microbiol., 7.10.3389/fmicb.2016.00494 ↗
81. Scholz, M., Reske, T., Böhmer, F., Hornung, A., Grabow, N., and Lang, H. (2017). In Vitro Chlorhexidine Release from Alginate Based Microbeads for Periodontal Therapy. PLoS ONE, 12.10.1371/journal.pone.0185562 ↗
82. Lyophilized Alginate-Based Microspheres Containing Lactobacillus Fermentum D12, an Exopolysaccharides Producer, Contribute to the Strain’s Functionality in Vitro10.1186/s12934-021-01575-6 ↗
83. Enhancing the Viability of Lactobacillus Plantarum Inoculum by Immobilizing the Cells in Calcium-Alginate Beads Incorporating Cryoprotectants10.1128/aem.56.10.3112-3116.1990 ↗
84. PH-Controlled Cell Release and Biomass Distribution of Alginate-Immobilized Lactococcus Lactis Subsp. Lactis10.1046/j.1365-2672.2001.01420.x ↗
85. Cell Release from Alginate Immobilized Lactococcus Lactis Ssp. Lactis in Chitosan and Alginate Coated Beads10.3168/jds.S0022-0302(01)74572-9 ↗
86. Encapsulation of Lactic Acid Bacteria with Alginate/Starch Capsules10.1007/BF02764447 ↗
87. Development of Probiotic-Loaded Microcapsules for Local Delivery: Physical Properties, Cell Release and Growth10.1016/j.ejps.2018.05.022 ↗
88. Growth Kinetics of Gel-Immobilized Yeast Cells Studied by on-Line Microscopy10.1007/BF00192090 ↗
89. Effect of Cryopreservation and Lyophilization on Viability and Growth of Strict Anaerobic Human Gut Microbes10.1111/1751-7915.13265 ↗
90. Foitzik, C., and Merten, H.A. (1999). Restitutio Ad Integrum. Vom Knochenersatz Zum Knochenaufbau, Spitta.
91. Evaluation Oralchirurgischer Augmentationsmaterialien—Ein Tierexperimentell Histomorphologischer Vergleich
92. Preservation of Viability and Antibacterial Activity of Lactobacillus Spp. in Calcium Alginate Beads10.1016/j.ejps.2010.08.008 ↗
93. Baumgartner, A., and Picot, C.E. (1989). Molecular Basis of Polymer Networks, Spring.10.1007/978-3-642-75044-1 ↗
94. Controlled and Targeted Drug Delivery Strategies towards Intraperiodontal Pocket Diseases10.1046/j.1365-2710.2000.00261.x ↗
95. Advanced Drug Delivery Approaches against Periodontitis10.3109/10717544.2014.935531 ↗
96. The Role of Controlled Drug Delivery for Periodontitis10.1902/jop.2000.71.1.125 ↗
97. Methods for the Immobilization of Microbial Cells10.1016/B978-0-12-041104-7.50008-7 ↗
98. Controlled Release Bioadhesive Microspheres: I. A Novel Electrobalance-Based Method to Study Adhesive Interactions between Individual Microspheres and Intestinal Mucosa10.1016/0168-3659(95)00011-V ↗
99. Protein Release from Alginate Matrices10.1016/S0169-409X(97)00124-5 ↗
100. A Focus on Mucoadhesive Polymers and Their Application in Buccal Dosage Forms10.1016/j.jddst.2015.06.016 ↗